Line 299: | Line 299: | ||
<li><a href="https://2016.igem.org/Team:British_Columbia/Project/Bio-Pathways">Biosynthetic Pathways</a></li> | <li><a href="https://2016.igem.org/Team:British_Columbia/Project/Bio-Pathways">Biosynthetic Pathways</a></li> | ||
<li><a href="https://2016.igem.org/Team:British_Columbia/Project/Consortia">Consortia</a></li> | <li><a href="https://2016.igem.org/Team:British_Columbia/Project/Consortia">Consortia</a></li> | ||
+ | <li><a href="https://2016.igem.org/Team:British_Columbia/Proof">Proof</a></li> | ||
</ul> | </ul> | ||
</li> | </li> | ||
Line 372: | Line 373: | ||
<li><a href="https://2016.igem.org/Team:British_Columbia/Project/Bio-Pathways">Biosynthetic Pathways</a></li> | <li><a href="https://2016.igem.org/Team:British_Columbia/Project/Bio-Pathways">Biosynthetic Pathways</a></li> | ||
<li><a href="https://2016.igem.org/Team:British_Columbia/Project/Consortia">Consortia</a></li> | <li><a href="https://2016.igem.org/Team:British_Columbia/Project/Consortia">Consortia</a></li> | ||
+ | <li><a href="https://2016.igem.org/Team:British_Columbia/Proof">Proof</a></li> | ||
</ul> | </ul> | ||
</li> | </li> |
Revision as of 02:26, 20 October 2016